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Introduction {#sec1}
============

Life is driven by a high diversity of metabolic processes, and each species or even strain may be characterized by its own metabolic particularities (e.g., [@bib62]). During evolutionary time and speciation processes, there are many ways that variations can be generated within metabolic pathways. Evolutionary models have been developed and experimentally tested to explain the arising of new pathways, but these efforts were focused on the activities of individual enzymes ([@bib54]). Changes in the metabolism may, however, also occur at a higher level of organization, notably an enzymatic replacement by non-orthologous genes encoding enzymes with identical biochemical function ([@bib37]; [Figure 1](#fig1){ref-type="fig"}, left side), or a change in enzyme order, which leads to different main biosynthetic intermediates ([Figure 1](#fig1){ref-type="fig"}, right side). This kind of variability, which we refer to as "metabolic drift" in this article, is possible due to substrate promiscuity of the enzymes and may be an important driver of evolution ([@bib55]).Figure 1The Hypothesis of Metabolic Pathway Drift Based on Two Possible Elementary MechanismsStarting from an ancestral promiscuous pathway (main pathway in teal; upper part, alternative pathway in olive green), changes can occur either by non-orthologous gene displacement (in orange, left side) or by change in main enzyme order, leading to a different intermediate metabolite (in olive green, right side). Substrate promiscuity enables the same molecular transformation to occur on different molecules, making the enzyme able to catalyze two different reactions. Promiscuity can be secondarily lost, as shown on the left side, leading to the impossibility to observe the star-shaped metabolite in contemporary metabolic pathway 1.

The concept of "drift" has previously been used in the field of animal comparative developmental biology, where it was already used to explain how morphologically similar structures can be maintained even if there are substantial variations in the molecular mechanisms underlying their formation ([@bib74]). Here also, the use of "drift" is distinct from genetic drift, but, nevertheless, appropriate because chance and not selection explains how changes occur. The concept was more recently extended to plants, where such cases have been observed in leaf development ([@bib73]). It was later exported to the fields of protein evolution ([@bib25]) and gene expression evolution ([@bib56]). Here, we hypothesize that the evolutionary concept of drift could also adequately explain the strict functional conservation of many metabolic pathways, despite variations in the underlying mechanisms ([Figure 1](#fig1){ref-type="fig"}).

To study metabolic drift by non-orthologous gene displacement ([Figure 1](#fig1){ref-type="fig"}, left part), classical comparative genomic approaches can generate hypotheses that can be experimentally checked using targeted metabolic profiling combined with inactivation of enzyme-encoding genes by reverse genetics ([@bib46], [@bib69]). However, in case of drift by change in enzyme order ([Figure 1](#fig1){ref-type="fig"}, right part), it is necessary to combine both genomic and metabolomic data and to introduce a knowledge-based approach that implements reasoning in the manner of a biochemist. Such inter-disciplinary strategies have already been used to design experiments for the analysis of auxotrophic mutants in yeast ([@bib34]) or for synthetic biology, where *ab initio* pathway inference is done to find a biosynthetic route that is not necessarily present in nature ([@bib36]). We hypothesize that similar tools can also be used to group biochemical reaction variants based on shared ancestry and to infer undescribed pathways that may be present in emerging model species.

To test this hypothesis, we have implemented a semi-automatic analogy reasoning approach, which we use to study two distinct metabolic pathways, the sterol pathway and the mycosporine-like amino acid (MAA) pathway, in the red alga *Chondrus crispus*. Red algae are sufficiently distant from terrestrial plants to anticipate substantial metabolic drift compared with the known pathways in organisms such as *Arabidopsis thaliana*, yet *C. crispus* has been subject to biological studies for more than two centuries ([@bib14]). Notably, its genome was sequenced and annotation was performed with a focus on metabolic features ([@bib13]), and there is extensive literature available describing its metabolome ([@bib76], [@bib64], [@bib42], [@bib47], [@bib31], [@bib71], [@bib38], [@bib19], [@bib6], [@bib58], [@bib49], [@bib2], [@bib21], [@bib39], [@bib57], [@bib75], [@bib65], [@bib63], [@bib5], [@bib7], [@bib23], [@bib41]).

The sterol metabolism was chosen as one focus point, because there is extensive knowledge about this pathway at the comparative genomics level ([@bib17]). Furthermore, analytical standards are available for different sterol molecules, enabling their identification by mass spectrometry (MS) ([@bib70]). MAA synthesis, on the other hand, involves combination of different building blocks, and analytical standards are lacking for this class of compounds, limiting metabolite identification to putative annotated compounds based on spectral similarity with spectral libraries ([@bib70]). Therefore the reconstruction of MAA pathway raised the problem of integrating unannotated compounds that were identified uniquely based on their m/z ratio.

By implementing a semi-automatic analogy reasoning approach that integrates both metabolite and genomic data, we here propose an exhaustive model for both metabolic pathways in *C. crispus* and provide strong indications for the importance of metabolic drift in shaping these pathways. We furthermore consolidated at least part of these hypotheses with targeted metabolite profiling of metabolic intermediates predicted in the models.

Results {#sec2}
=======

Genome-Scale Metabolic Network Enriches the Inferred Basic Integrated Metabolism for *C. crispus* {#sec2.1}
-------------------------------------------------------------------------------------------------

Genome-scale metabolic networks (GSMNs) are graph-based representations of enzymatic reactions assumed to occur in a given organism. In this framework, an enzymatic reaction denotes a chemical reaction that transforms one or several metabolic substrates into one or several metabolic products under the control of an enzyme that can be associated with a gene in the considered species.

We used the tool AuReMe (Automatic Reconstruction of Metabolic models) dedicated to "à la carte" reconstruction of GSMNs ([@bib1]) to reconstruct a GSMN of *C. crispus*. This GSMN comprised in total 2,024 enzymatic or transport reactions ([Table 1](#tbl1){ref-type="table"}). Among them, 595 reactions were recovered from annotation-based searches from the *C. crispus* genome annotation ([@bib13]) with the Pathway Tools suite ([@bib77]) and the MetaCyc database ([@bib12]). In addition, 1,429 reactions were included in the network according to orthology evidences with protein sequences encoding enzyme reactions in the *Arabidopsis thaliana* GSMN ([@bib16]), the *Galdieria sulphuraria* *GSMN* (based on genome data from [@bib66]), or the *Ectocarpus siliculosus GSMN* ([@bib15], [@bib1]). A biomass reaction was established based on the previous *E. siliculosus* data, defining a list of 33 compounds to be produced to consider the network functional ([@bib60]). According to this biomass reaction, the network was manually gap-filled to unblock the production of L-alpha-alanine with an alanine dehydrogenase reaction whose associated gene had been incorrectly annotated in the *C. crispus* genome. The predicted maximal growth rate was then 2.43 g.gDW^−1^.h^−1^ (gram per gram dry weight per hour). As shown in [Table 1](#tbl1){ref-type="table"}, the *C. crispus* GSMN is comparable in size with the *E. siliculosus* GSMN. A total of 254 pathways are complete, including those involved in central metabolism of carbohydrates, fatty acids, and amino acids, as well as those related with photosynthesis. The greatest contributor to the inferred reaction set was the phylogenetically close red microalga *G. sulphuraria,* which provided 1,361 reactions.Table 1Comparison of Global Features of Genome-Scale Metabolic Networks from Macroalgae and Other Chlorophyllian EukaryotesSpeciesReactionsEnzymesMetabolitesPathwaysReference*C. crispus*2,0242,0062,1961,108This study, before curation*E. siliculosus*1,9772,2812,1321,101[@bib1]*Ectocarpus subulatus*2,0742,4452,1731,083[@bib18]*A. thaliana*1,5671,4191,748796[@bib16]*Chlamydomonas reinhardtii*3,0831,3551,133522[@bib29]

Building a Catalog of Evidenced Metabolites in *C. crispus* Using Metabolomic Data {#sec2.2}
----------------------------------------------------------------------------------

To better understand the specificities of *C. crispus*, we built a catalog of metabolic compounds attested to be produced by the alga. To that goal, we reviewed the literature to collect experimental evidence of presence of all reported metabolites. To have more species-specific data on sterol and MAA synthesis we also experimentally tested for the presence of these compounds and their precursors in *C. crispus* using MS analysis. In this way, we assembled a set of 142 metabolites that are reported in [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}. Those metabolites broadly cover various classes of amino acids, carbohydrates, and lipids. We divided this dataset into two main categories: 85 database metabolites, which are already indexed into Metacyc ([Table S1](#mmc1){ref-type="supplementary-material"}), and 57 orphan metabolites, not yet indexed ([Table S2](#mmc1){ref-type="supplementary-material"}). In addition, we have acquired additional experimental data on two pathways for which molecules are in both categories: the sterol and the MAA pathways.

Our MS data confirmed previous findings and also pointed out possible additional precursors and intermediary metabolites in sterol and MAA biosynthesis pathways. More precisely, the results of these analyses of sterols are found in [Table 2](#tbl2){ref-type="table"}. In addition to confirming the presence of eight previously identified sterols (brassicasterol, campesterol, cholesterol, 7-dehydrocholesterol, desmosterol, lathosterol, β-sitosterol, and stigmasterol), we identified in *C. crispus* an immediate precursor of sterols, i.e., squalene ([Figure S1](#mmc1){ref-type="supplementary-material"}). However, we did not find evidence for cycloeucalenol, ergosterol, fucosterol, and zymosterol, which are intermediates present in other eukaryotes ([@bib17], [@bib69]). We also did not find cycloartenol, contrary to a previous report in *C. crispus* using thin-layer chromatography ([@bib2]). This negative finding is strengthened by the fact that we are able to identify the cycloartenol standard when added in algal extract ([Figure S2](#mmc1){ref-type="supplementary-material"}).Table 2List of Sterols Profiled in This Study, and Comparisons with Previous StudiesAnalyzed CompoundsMolecular FormulaFound in This StudyPrevious EvidenceBrassicasterolC~28~H~46~OYes[@bib64] (GC-MS), [@bib71] (TLC, GC-MS)CampesterolC~28~H~48~OYes[@bib71] (TLC, GC-MS)CholesterolC~27~H~46~OYes[@bib64] (TLC, GC-MS), [@bib71] (TLC, GC-MS)CycloartanolC~30~H~52~ONoNot reportedCycloartenolC~30~H~50~ONo[@bib64] (TLC), [@bib2] (TLC)CycloeucalenolC~30~H~50~ONoNot reported7-DehydrocholesterolC~27~H~44~OYes[@bib71] (TLC, GC-MS)DesmosterolC~27~H~44~OYes[@bib64] (TLC, GC-MS), [@bib21] (GC-MS)ErgosterolC~28~H~44~ONoNot reportedFucosterolC~29~H~48~ONoNot reportedLanosterolC~30~H~50~ONo[@bib64] (TLC)LathosterolC~27~H~46~OYes[@bib21] (GC-MS)β-SitosterolC~29~H~50~OYes[@bib64] (GC-MS), [@bib71] (TLC, GC-MS)SqualeneC~30~H~50~YesNot reportedStigmasterolC~29~H~48~OYes[@bib64] (GC-MS), [@bib71] (TLC, GC-MS)ZymosterolC~27~H~44~ONoNot reported[^3][^4]

Similar experiments were carried out for the MAA pathway, and corresponding data are summed up in [Table 3](#tbl3){ref-type="table"}. Using liquid chromatography-MS (LC-MS) profiling we confirmed the presence of six MAAs in *C. crispus* (see references in [Table 3](#tbl3){ref-type="table"}): asterina-330, palythene, palythine, palythinol, porphyra-334, and shinorine. In addition, we identified mycosporine-glycine in *C. crispus*. The relative abundance of MAAs varied between sampling dates ([Figure 2](#fig2){ref-type="fig"}), which is consistent with a report of MAA variation in the Galway Bay, Ireland ([@bib23]). We noticed that two unknown peaks potentially corresponding to MAAs were detected in our samples. These peaks exhibit m/z ratios consistent with peaks reported in a study on 40 red algae by [@bib41]. Specifically, we found a peak at m/z = 270.3 that does not match with any already identified candidate MAA, which we named MAA1, and a second one at m/z = 302.3, which we named MAA2.Table 3List of Mycosporine-like Amino Acids Identified in This Study and Comparisons with Previous StudiesAnalyzed CompoundsMolecular FormulaFound in This StudyPrevious EvidenceAsterina-330C~12~H~20~N~2~O~6~Yes[@bib5] (LC-MS-MS); [@bib23] (LC-MS)MAA1compatible with m/z 270.272Yes[@bib41] (HPLC)MAA2compatible with m/z = 302.3117Yes[@bib41] (HPLC)Mycosporine-glycineC~10~H~15~NO~6~Yesnot reportedPalythineC~10~H~16~N~2~O~5~Yes[@bib31] (UV + LC-MS); [@bib5] (LC-MS-MS); [@bib23] (LC-MS)Usujirene/PalytheneC~13~H~20~N~2~O~5~Yes[@bib31] (UV + LC-MS)PalythinolC~13~H~22~N~2~O~6~ (m/z = 302.3117)No[@bib31] (UV + LC-MS), [@bib5] (LC-MS-MS)Porphyra-334C~14~H~22~N~2~O~8~Yes[@bib5] (LC-MS-MS)ShinorineC~13~H~20~N~2~O~8~Yes[@bib31] (UV + LC-MS), [@bib5] (LC-MS-MS)[^5]Figure 2Composition and Seasonal Variation *(MS Relative Quantification)* of MAAs in *C. crispus*The four most abundant compounds, including the unknown MAA1, are on the left panel. The four less abundant compounds, including MAA2, are on the right panel.

Secondary Metabolism Evidenced by Metabolomic Data Is Only Partially Accurately Described in the *C. crispus* GSMN {#sec2.3}
------------------------------------------------------------------------------------------------------------------

To investigate the accuracy of GSMNs to describe the synthesis pathway of secondary metabolites of importance, we studied the capability of the *C. crispus* GSMN to describe synthesis pathways of metabolic compounds whose presence have been evidenced in the alga. Among those 142 metabolites, only 85 (60%) were indexed in the MetaCyc database version 20.5 ([Table S1](#mmc1){ref-type="supplementary-material"}). The GSMN could provide synthesis pathways for only 59 metabolites already indexed in the Metacyc database. Those metabolites were amino acids (19), fatty acids (12), aldehydes (6), aliphatic alcohols (3), carotenoids (3), ketones (2), carboxylic acids (2), a halocarbon, a galactolipid, an oxylipin, a tetrapyrrole, an MAA, a nucleotide sugar, a methylketone, and a polyol. The synthesis of the 29 remaining metabolites indexed in the MetaCyc database could not be explained by any addition of enzymatic reactions in the database (failure of the exhaustive gap-filling procedure). The metabolites belonged to the following classes: fatty acids (8), sterols (8), alkanes (2), carotenoids (2), carragheens (2), aliphatic alcohols (2), an aldehyde, and a halocarbon. For the 57 metabolites that had not yet been indexed in MetaCyc ([Table S2](#mmc1){ref-type="supplementary-material"}), it was impossible to generate hypotheses on their synthesis pathways. There were galactolipids (12), oxylipins (9), fatty acids (8), MAAs (6), alcohols (6), unconventional amino acids (3), tetrapyrroles (3), alkanes (2), carboxylic acids (2), ketones (2), a heteroside, a sterol, a phospholipid, and an aldehyde.

Building a Knowledge Base of Enzymatic Reactions and Molecules in Sterol and MAA Synthesis {#sec2.4}
------------------------------------------------------------------------------------------

To enable the incorporation of the orphan metabolites that were not yet in MetaCyc and derive possible synthesis pathways for sterols and MAAs, we built two knowledge bases describing the existing knowledge about known enzymatic reactions and molecules involving sterols or MAAs (available on <https://github.com/pathmodel/pathmodel>). They are encoded in the Pathmodel datafiles sterol_pwy.lp and MAA_pwy.lp, both accessible in the pathmodel/data folder of the Github repository. In these knowledge bases, molecules are described by *atoms* (identified by a number and atom types) and *bonds* (identified by atom numbers and bond type) as highlighted in green on [Figure 3](#fig3){ref-type="fig"}. Atom numbers were assigned manually to ensure consistency between molecules from the same family and followed IUPAC conventions when existing ([@bib52]). Molecules can be automatically associated with a theoretical m/z ratio, calculated using their chemical formula, as described in the program MZComputation.lp.Figure 3The Two Reasoning Methods Implemented in Pathmodel(A) Inference of a reaction between two known molecules.(B) Inference of reaction and metabolite structure corresponding to an unassigned m/z peak. Input data encoded in the knowledge base are in black; inferred reactions and metabolite structures are in green. In both cases, reaction substructure identification followed by inference of molecular transformations are common intermediate steps.

Enzymatic reactions, denoted by *reaction*, model the link between two molecules (a reactant and a product, e.g., *reaction*(*rxn_4243, \"sitosterol\", \"stigmasterol\"*)). They are associated with cross-references to MetaCyc pathway IDs when possible.

The MAA knowledge base ([Figure 4](#fig4){ref-type="fig"}) contained 13 enzymatic reactions involving 12 molecules. It first contained the shinorine biosynthesis pathway (MetaCyc: PWY-7751), corresponding to the best understood part of the pathway ([@bib67]). We also encoded in the knowledge base an extended version of the amino acid C3-transfer reaction (MetaCyc: RXN-17371) to incorporate the hypothesis that the enzyme performing the C3-transfer of serine can also perform the C3-transfer of threonine, leading to porphyra-334 ([@bib9]). We also incorporated additional reactions hypothesized in the literature ([@bib11]), for which either the substrate or the product was an MAA described in *C. crispus*. We finally added to the database the four orphan MAAs listed in [Table S2](#mmc1){ref-type="supplementary-material"}, as well as two unknown molecules (MAA1 and MAA2) for which we had an experimental support for peaks corresponding to unassigned m/z ratios, as well as mycosporine-glycine, which was here identified in *C. crispus*.Figure 4A Model for MAA Biosynthesis Pathway in *C. crispus*PWY-7751: shinorine biosynthesis pathway. The figure legend details the various data sources integrated to infer the pathways. Stars indicate reactions, and squares indicate molecules. In light blue boxes: reactions and metabolites inferred through Pathmodel.

The sterol knowledge base ([Figure 5](#fig5){ref-type="fig"}) contained 15 enzymatic reactions involving 24 molecules, including the eight unproducible sterols and the orphan molecule 22-dehydrocholesterol, which was not linked to any reaction. We encoded the «early side-chain reductase» (early SSR) pathway based on the model previously published for tomato ([@bib69]), which was added in MetaCyc upon our request (MetaCyc: PWY18C3-1). It also included portions of the canonical plant sterol biosynthesis pathway (MetaCyc: PWY-2541; [@bib8]), as well as portions of the animal sterol synthesis pathway (MetaCyc: PWY66-4, [@bib50]).Figure 5A Model for Sterol Biosynthesis in *C. crispus*Early SSR: pathway involving an early sterol side-chain reduction (SSR), also present in solanacean plants (PWY18C3-1). In light blue box: late SSR pathway, involving a late sterol SSR, so far only described in *C. crispus*. Portions identical with the plant sterol biosynthesis pathway (PWY-2541) are also boxed. Ovals indicate molecular transformations.

Inferring Molecular Transformations from a Database of Enzymatic Reactions {#sec2.5}
--------------------------------------------------------------------------

Based on these examples, we hypothesize that these orphan molecules challenge the ability of the GSMN to produce them because of lacks in secondary metabolism synthesis pathways that enable the description of all possible molecular transformations between compounds catalyzed by a small family of enzymes. First, we define a molecular transformation to be a chemical reaction transforming a metabolite into another metabolite by operating on a specific part of the metabolite structure, called a *substructure*. We define a *substructure* to be a set of one of several atoms associated with one or several bonds in a given molecule. For instance, *substructure* ("simple bond 22-23") denotes a simple bond between atoms 22 and 23, such as in sitosterol on [Figure 3](#fig3){ref-type="fig"}A.

Importantly, an enzymatic reaction involving a single reactant and a single product can be defined as a molecular transformation by assuming that the enzyme enables the transformation of a metabolite site into another. Therefore, for each reaction involving a single reactant and a single product, we call *pair of transformed substructures* the substructure of the reactant (for instance, as shown in [Figure 3](#fig3){ref-type="fig"}A, simple bond between atoms 22 and 23 in sitosterol) and the substructure of the reaction product (for instance, as shown in [Figure 3](#fig3){ref-type="fig"}A, double bond 22-23 in stigmasterol).

Pairs of transformed substructures can be computed by removing all the atoms and bonds that are common to both reactant and product molecules, all atoms and bonds being previously ordered. For the sterol and MAA cases, we identified pairs of transformed substructures with a reasoning-based approach (see [Methods](#sec4){ref-type="sec"}) and then annotated them to describe a catalog of molecular transformations associated with known enzymatic reactions. For instance, the transformation replacing a simple bond between atoms 22 and 23 (as exhibited in sitosterol) into a double bond 22-23 (as exhibited in stigmasterol) is a c22 desaturation, described by the term *transformation*(*c22_desaturation, simple bond 22-23, double-bond 22-23*).

The complete list of molecular transformations for the sterol and MAA reactions is given in [Table S5](#mmc1){ref-type="supplementary-material"}. The sterol enzymatic reaction database (15 reactions) yields 12 molecular transformations, whereas the MAA enzymatic reaction database (13 reactions) yields 9 molecular transformations. Reasoning on molecular transformations instead of enzymatic reactions, we reduce the complexity of the reaction set by abstracting a library of molecular transformations that can be applied to other known molecules belonging to the same chemical family.

Inferring Molecular Compounds and Enzymatic Reactions from a Database of Molecular Transformations {#sec2.6}
--------------------------------------------------------------------------------------------------

We used these databases of molecular transformations to infer putative new molecules and reactions.

To that goal, we assumed that for any molecular transformation from a substructure S1 to a substructure S2, and any pair of metabolites A and B, a *putative enzymatic reaction* can occur from the reactant A to the product B as soon as (1) the molecule A contains the substructure S1, (2) the molecule B contains the substructure S2, and (3) the molecules A and B have identical structures (e.g., same numbered atoms and bonds) for all atoms and bonds to the exception of S1 and S2 substructures. An example is shown in [Figure 3](#fig3){ref-type="fig"}A: cholesterol and 22-dehydrocholesterol share a sterane skeleton. The only difference between these molecules is that cholesterol has a simple bond between atoms 22 and 23, whereas 22-dehydrocholesterol has a double bond between atoms 22 and 23. As the transformation from a simple bond to a double bond between atoms 22 and 23 has been evidenced in the reaction database (reaction from sitosterol to stigmasterol, [Figure 3](#fig3){ref-type="fig"}), we assume that a putative enzymatic reaction exists between cholesterol and 22-dehydrocholesterol and that it should be a c22_desaturation.

In addition, we assumed that, for a given molecular transformation, a given metabolite A and an experimental mass-to-charge ratio m/z corresponding to an unassigned peak, a *putative metabolite* B can be produced as soon as (1) the theoretical mass-to-charge ratio of B equals the experimental m/z and (2) A can be transformed into B according to a putative enzymatic reaction associated with the selected molecular transformation. An example is depicted in [Figure 3](#fig3){ref-type="fig"}B. We consider that the molecule MAA2 is a putative derived metabolite of porphyra-334 because its mass-to-charge m/z = 302.3117 corresponds to an observed peak in our measurements and that it can be obtained from porphyra-334 by removing a carboxyl group from carbon 18, a transformation named *decarboxylation*, which occurs in the enzymatic reaction from shinorine to asterina-330.

With these two assumptions, we introduce the concept of *putative synthesis pathway* computed from a source molecule A, a list of target molecules, a list of molecular transformations, a list of putative metabolites, a list of corresponding theoretical mass-to-charge m/z, and a list of forbidden molecules, for which we have analytical standards that did not match experimental peaks. From these inputs, a putative synthesis pathway is a family of putative reactions connecting the source to all targets metabolites such that (1) all reactions are consistent with the database of molecular transformations, (2) all reactants and products of the reactions are allowed either metabolites or putative metabolites matching with the allowed theoretical mass-to-charge ratio m/z, (3) no transformation associated with the pathway can produce any of the forbidden molecules, and (4) a minimal number of reactions is used to connect the source to the targets.

The Pathmodel method was developed as a prototype implementation of a semi-automatic analogy reasoning approach ([Figure 3](#fig3){ref-type="fig"}). Its aim is to infer putative synthesis pathways, to connect orphan metabolites, not yet indexed in metabolic databases, according to the known enzymatic reactions. The Pathmodel method takes as input a knowledge base including a set of known metabolites, a set of known enzymatic reactions, a set of observed mass-to-charge (m/z) ratios for unknown metabolites, an initial source metabolite, a family of targeted metabolites, and a list of forbidden molecules. Metabolites are described by their numbered atoms and bounds. Pathmodel then computes the list of molecular transformations associated with the database of enzymatic reactions and putative synthesis pathways of the targeted metabolites from the source metabolite. More precisely, for each pair of metabolites not linked by a reaction in the knowledge base, the method checks whether a molecular transformation can occur between them (deductive reasoning) and further derives from known reactions candidate metabolites corresponding to observed unassigned m/z ratios (analogical reasoning). These are the bases for iterating the selection of potential reactants or products and the inference by a reasoning component of new reaction occurrences or new metabolites. It was implemented using a logic programming approach known as *Answer Set Programming* ([@bib44], [@bib20], see [Methods](#sec4){ref-type="sec"}). An example of this reasoning is given in [Figure 3](#fig3){ref-type="fig"}.

### Application of Pathmodel to the MAA Synthesis Pathway {#sec2.6.1}

We first used Pathmodel to compute the synthesis pathway for MAA1 and palythine from sedoheptulose-7-phosphate according to the MAA enzymatic reaction database described above. We also assumed that Z-palythenic acid was defined as a forbidden molecule according to the absence of a corresponding peak in *C. crispus* extracts.

The putative pathway for MAA synthesis obtained by our method is shown in [Figure 4](#fig4){ref-type="fig"}. Thanks to this approach, the knowledge base of MAA biosynthesis could be enriched with two putative molecule structures and three putative enzymatic reactions. In addition, the reactions that we compiled from the literature but are not yet indexed in MetaCyc will be submitted to the next release.

A first output of this approach is a pathway leading to a molecule structure compatible with our measured mass-to-charge ratio m/z = 270.3. It was therefore possible to infer the hypothetical structure shown in [Figure 4](#fig4){ref-type="fig"} for this unassigned compound, named MAA1, in MS data. The predicted transformation leading from asterina-330 to MAA1 is a dehydration (in purple), a molecular transformation already observed between other MAAs such as porphyra-334 and Z-palythenic acid, a compound not identified in *C. crispus* ([Figure 4](#fig4){ref-type="fig"}).

Another output of this approach is to suggest a putative involvement of decarboxylation and dehydration transformations in MAA biosynthesis pathways. As no candidate enzymes were mentioned so far in the literature related to MAA biosynthesis pathways, we performed a semantic search on the GSMN from *C. crispus*, to identify other enzymes that may perform those molecular transformations on a serine coupled with other chemical building blocks. Serine decarboxylation indeed occurs in phospholipid metabolism and was inferred in the *C. crispus* GSMN based on orthology with *G. sulphuraria*. The candidate gene is CHC_T00008892001, annotated as phosphatidylserine decarboxylase. Interestingly, there is some evidence of catalytic promiscuity for this enzyme, enabling it to also decarboxylate a threonine residue ([@bib27]). Therefore, we hypothesize that this enzyme in *C. crispus* may also perform serine/threonine decarboxylation on a serine/threonine linked to a mycosporine-glycin.

A final interesting feature of the MAA synthesis pathways is the inferred enzymatic reaction required to decarboxylate shinorine and porphyra-334 and further dehydrate their derivatives. These reactions were added to the pathway to take into account the fact that Z-palythenic acid was absent in *C. crispus* extracts. Such an absence does not support dehydration occurring before decarboxylation, as proposed in other species ([@bib11]), and therefore does not allow finding any chains of reaction producing palythinol, a compound previously considered to be present in *C. crispus* based on UV + LC-MS or LC-tandem MS data ([@bib31], [@bib5]). We noticed, however, that there is no synthesis-based analytical standard available for verifying this prediction. To identify alternative routes for the production of porphyra-334, we ran Pathmodel by allowing the production of putative metabolites with m/z ratio of 302.3177 (the one of palythinol). Pathmodel then predicted an additional intermediate with m/z ratio of 302.3177, named MAA2 on [Figure 4](#fig4){ref-type="fig"}. From a genomic viewpoint, switching palythinol with MAA2 does not necessitate a candidate enzyme to perform hydrogenation and demethylation on an MAA-like substrate ([Figure 4](#fig4){ref-type="fig"}) and thus reduces the number of unassigned enzymatic activities to candidate genes. We thus included this alternative route in the MAA synthesis pathway that is consistent with the possible absence of Z-palythenic acid.

### Application of Pathmodel to the Sterol Synthesis Pathway {#sec2.6.2}

The Pathmodel approach was also applied to the sterol biosynthetic pathway in *C. crispus* ([Figure 5](#fig5){ref-type="fig"}). To that goal, we used it as an enzymatic reaction database described below. The source metabolite was cycloartenol. The targeted metabolites were 22-dehydrocholesterol, brassicasterol, and stigmasterol. In addition, forbidden metabolites were ergosterol, fucosterol, and zymosterol, which are compounds with no detection result using targeted profiling with analytical standards.

We decided to use cycloartenol even if we did not find it by gas chromatography (GC)-MS for the two following reasons. First, a cycloartenol synthase from the red alga *Laurencia dendroidea* was cloned and expressed in yeast cells, where it is able to transform squalene into cycloartenol, even if the authors did not report cycloartenol identification in the whole alga by GC-MS ([@bib10]). Second, unambiguous cycloartenol derivatives are known in another florideophyte red alga, *Tricleocarpa fragilis* ([@bib28]). Therefore, we considered more parsimonious to hypothesize that cycloartenol is present and below the limit of experimental detection rather than considering that this step is performed via an unknown intermediate.

We propose two alternative synthesis pathways from cycloartenol to cholesterol, depending on when the side-chain reductase (SSR) enzyme is acting ([Figure 5](#fig5){ref-type="fig"}).

If *C. crispus* uses the « early SSR » pathway ([@bib69]), the metabolic intermediates would be identical to tomato, but there would be an important difference concerning the enzymes. Indeed, the genes encoding SSR are duplicated in Solanaceae (tomato and potato) but not in the *C. crispus* genome or in any red algal genome and in other plants, analyzed so far ([Figure S3](#mmc1){ref-type="supplementary-material"}). The unduplicated SSR from non-solanaceous plants is known to be catalytically promiscuous, and indeed Pathmodel suggested that SSR could act on all possible intermediates ([Figure 5](#fig5){ref-type="fig"}).

Another alternative synthesis pathway inferred by Pathmodel consists in producing methylated sterols through C24-methylation on desmosterol ([Figure 5](#fig5){ref-type="fig"}). This is in agreement with the identification of a methylated sterol, 24-methylenecholesterol, in *C. crispus* ([@bib71]) and builds on with other reports about methyltransferase catalytic promiscuity across land plants and green algae ([@bib53], [@bib26]). This option highly reduces the number of non-identified methylated intermediates. Indeed, in land plants, a first methylation, involving methyltransferases, occurs directly on cycloartenol, whereas the second one occurs later on 24-methylenelophenol, to produce methylated sterols like campesterol or brassicasterol ([@bib8]) with intermediates such as cycloeucalenol or fucosterol, both compounds for which we did not find any evidence of presence. By specifying in our model not to enable the production of fucosterol, we naturally omitted this possibility. This model seems also more relevant from a quantitative viewpoint with respect to the formation of cholesterol as the main sterol, because this late methylation step would enable the production of methylated sterols using the late SSR pathway.

A Complete Set of Candidate Enzymes for the *C. crispus* Sterol Synthesis Pathway {#sec2.7}
---------------------------------------------------------------------------------

To identify the enzymes associated with the sterol synthesis pathways, we carried out a comparative genomic analysis. Results are summed up in [Table S6](#mmc1){ref-type="supplementary-material"}. In line with previous analyses on sterol biosynthesis gene families in eukaryotes ([@bib17]) or more specifically in green plants ([@bib69]), the candidate sterol synthesis enzyme set shows a mixture of conservation and divergence. Seven enzymes are encoded by genes that are conserved as 1:1 orthologs, whereas four of them either underwent lineage-specific duplications (squalene epoxidase and C-4 demethylase) or were lost or may have been replaced by distant paralogs (C24 and C24′ methylases and C22 desaturases). In one case, we found no homolog of known plant or animal enzymes performing delta-7/delta-8 isomerization in the *C. crispus* genome, but we found a 1:1 ortholog of ERG2, the gene that secondarily took up this function in yeast ([@bib17]). Another similar case in the sterol synthesis pathway occurs in diatoms, where the epoxisqualene cyclase, otherwise conserved in eukaryotes, was secondarily lost and replaced by a protein belonging to the fatty acid hydroxylase superfamily ([@bib59]). We consider the ERG2 ortholog to be the best candidate for delta-7/delta-8 isomerization in *C. crispus*, but it is also possible that this reaction is performed by an enzyme encoded by a taxonomically restricted orphan gene ([@bib32]).

A Complete View of Algal Primary Metabolism Associated with MAA and Sterol Synthesis {#sec2.8}
------------------------------------------------------------------------------------

The final GSMN associated with *C. crispus* is constituted of the initial GSMN, enriched with models curated in detail for the sterol and the MAA synthesis pathways. It was therefore reconstructed from both the genome data and the metabolomic data, using the extraction of molecular transformations implemented in Pathmodel ([Figure 6](#fig6){ref-type="fig"}). The final GSMN contains 2,207 metabolites, including the eight initial target sterols that are now producible based on Pathmodel inferences as well as seven formerly orphan metabolites (six MAAs and 22-dehydrocholesterol). In this way, we increased the proportion of producible targets from 69.4% (59/85) up to 80% (74/92). The final GSMN is available as a wiki website at the following address: <https://gem-aureme.genouest.org/ccrgem/index.php/Main_Page>. This website is open for further community curation and will serve as the central point to later integrate additional biochemical knowledge about *C. crispus.* More widely, the curation effort on those pathways will also benefit the entire GSMN community. As already done for the early SSR pathway (now MetaCyc: PWY18C1-3), we will systematically suggest the inclusion of biochemical data used in Pathmodel in the next versions of MetaCyc.Figure 6Reconstruction Scheme for the Genome-Scale Metabolic Network of *C. crispus*Green boxes indicate starting data and resulting knowledge. Blue boxes indicate the tools that were used to analyze and integrate genomic and metabolomic data. The part overshadowed in gray indicates tools that are already integrated in the AuReMe workflow ([@bib1]).

Discussion {#sec3}
==========

In this study we present an extensive analysis of the sterol and MAA biosynthetic pathways in the red alga *C. crispus*, integrating automatic metabolic network reconstruction, manual curation, metabolite profiling, and semi-automatic analogy reasoning approach based on molecular similarity and dissimilarity to generate hypotheses on metabolic pathways associated with secondary metabolism and metabolites, which are not described in GSMN reference databases such as Metacyc. Three main conclusions can be derived from the presented research. (1) Our findings underline the usefulness of semi-automatic analogy reasoning approaches to link orphan metabolites to existing pathways through the prediction of molecular transformations to infer reactions based on molecular similarity and dissimilarity. (2) These models support our hypothesis of drift as an evolutionary mechanism shaping the metabolism of living organisms. (3) We propose models of sterol and MAA biosynthesis in *C. crispus* and partially validate these models by metabolite profiling.

Semi-automatic Analogy Reasoning Approaches to Integrate Orphan Metabolites {#sec3.1}
---------------------------------------------------------------------------

Our study demonstrates that data on metabolite occurrence can be explicitly incorporated into the quality criteria for evaluating a GSMN. To deal with metabolic drift during metabolic network reconstruction, the incorporation of metabolite data is essential, because it puts further constraints on partially known pathways. Putting more emphasis on metabolites, especially the missing ones, creates methodological challenges regarding *ab initio* inferences of pathways when enzymes are not yet known, and we have shown that it is now possible to build tools to specifically address those challenges. The next issue is about the scalability of our approach. The Pathmodel version we present here is a working prototype that can already be applied to other metabolic pathways in *C. crispus* or in other organisms where genomic and metabolomic data are available.

Application of the Pathmodel Approach to Other Studies {#sec3.2}
------------------------------------------------------

The results presented in this study are a first step toward the further development of the underlying bioinformatic tools and their application to additional model biosynthesis pathways. Indeed, the Pathmodel tool was developed to support reasoning based on the metabolic pathway drift hypothesis to automatically infer reactions and metabolites. A key feature of the successful application of this strategy was the precision and the quality of the biochemical and biological knowledge encoded in the reaction and metabolite databases used as entries to Pathmodel. In particular, all metabolites have to be described with a homogeneous ordering of atoms to predict molecular transformations. Generalizing this approach to any other application will similarly require interactions between chemists, biologists, and computer scientists. Further improvements should be made to minimize the burden in manually entering molecular structures. It is not yet possible to fully automate the atom numbering during metabolic reaction, due to the intrinsic complexity of metabolic pathways. For example, the split of molecules during biochemical processes can generate inconsistent numbering ([Figure S5](#mmc1){ref-type="supplementary-material"}A) that can only be handled by resetting atom numbering from one step to another. This is already done in MetaCyc, but in a way that does not make possible to automatically number in the same manner atoms from different reactions that share a molecular transformation ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Other methods, like the CLCA approach ([@bib40]) already implemented ways to compare reactions sharing molecular transformations, and thus would provide lists of candidate reactions for molecular transformations, but the atom numbering during the comparisons does not allow simultaneous atom mapping between reactant and product ([Figure S5](#mmc1){ref-type="supplementary-material"}C) that we need in Pathmodel to abstract the molecular transformation. Therefore, following IUPAC atom encoding as much as possible seems to be the best way to combine atom mapping and abstraction of molecular transformations ([Figure S5](#mmc1){ref-type="supplementary-material"}D).

The second key feature of Pathmodel is to be focused on a selected pathway rather than on a complete genome-scale metabolic network. The selection of the relevant pathway to be considered, for instance, from preliminary evidences extracted from metabolomic analysis, is therefore a key pre-processing step to combine and filter the predictions of Pathmodel with genomic and metabolomic data. Practically, Pathmodel can already be used on any type of incomplete biochemical pathway on a molecule class for which there is knowledge about some biochemical reactions and orphan molecules not yet connected to each other by any reaction. The main limitation will be the user time necessary to properly encode the starting knowledge base.

Metabolic Drift as a Driver for Pathway Evolution {#sec3.3}
-------------------------------------------------

Whatever the actual topology of the sterol and MAA pathways in *C. crispus,* each discussed hypothesis has implications regarding metabolic pathway drift. All possible sterol pathways provide further strong candidate case studies for drift by non-homologous enzyme replacement, and the pathways inferred by Pathmodel provide candidate case studies for drift by enzyme inversion. The unresolved point with the sterol pathways is that, among eukaryotes, there is no consensus yet about the ancestral order of enzymatic reactions. Experimental data are too disparate across the tree of life to enable firm conclusions on this. In that respect, the MAA pathway is interesting, because if our hypothesis about decarboxylation of porphyra-334 before dehydration is true, this would mean that an enzymatic inversion took place in other lineages where porphyra-334 is first dehydrated to Z-palythenic acid and then decarboxylated to palythene. Here the limit is that, to date, enzymes are unknown for both reactions, so the system is not yet genomically tractable. Identifying close enzymatic inversions would be important to provide a mechanism for gradual divergence of pathways. Indeed, experimental analyses on *E. coli* have shown that drastic pathway rewiring by enzyme knockout or gene overexpression can led to toxic intermediates ([@bib33]).

Limitations of the Study {#sec3.4}
------------------------

Our arguments for the metabolic pathway drift hypothesis rely on comparisons between pathways from *C. crispus* and from distantly related species belonging to a few other phyla, such as land plants or animals. Additional support should become available from detailed comparisons based on additional eukaryotic lineages and, when possible, from multiple species in the same phylum. Finally, it remains to be determined to what extent chance and selection contributed in generating metabolic pathway diversity.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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The following reference appears in the Supplemental Information: [@bib4], [@bib22], [@bib24], [@bib30], [@bib35], [@bib43], [@bib45], [@bib51], [@bib61], [@bib68].
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